Identifying urine and blood markers for early detection of pancreatic cancer
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer
This study is looking for easy ways to spot pancreatic cancer early by testing urine and blood samples, so that people at high risk can get the right help sooner.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11009972 on NIH RePORTER |
What this research studies
This research focuses on finding non-invasive biomarkers in urine and serum that can help diagnose pancreatic cancer at an early stage when treatment is most effective. By analyzing samples from patients, the team aims to develop tests that can distinguish between early-stage pancreatic cancer and benign conditions. The study will utilize both retrospective and prospective data to create algorithms that improve the accuracy of these biomarkers. The ultimate goal is to provide a reliable screening method for high-risk populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for pancreatic cancer, such as those with a family history of the disease or certain genetic predispositions.
Not a fit: Patients with advanced pancreatic cancer or those without risk factors for pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis of pancreatic cancer, significantly improving survival rates and treatment outcomes.
How similar studies have performed: Other research has shown promise in using biomarkers for early cancer detection, suggesting that this approach could be effective.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Lokshin, Anna E. — University of Pittsburgh at Pittsburgh
- Study coordinator: Lokshin, Anna E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.